i3 Health News - Clinical Care Advances for the Multidisciplinary Team

This Week's Exclusive

Based on recent estimates, kidney cancer accounts for approximately 4% of all cancer diagnoses in the United States. An estimated 65,300 new cases are reported each year and more than 14,000 people die of the disease. Renal cell carcinoma (RCC), which comprises nearly 90% of all kidney cancers, is characterized by a lack of early warning signs, diverse clinical manifestations, and resistance to radiation and chemotherapy. As a result of its often asymptomatic pr...

Top Oncology Stories

Wednesday, January 23, 2019
Although hepatitis C infection is one of the leading causes of liver cancer, controversy is widespread regarding whether the direct-acting antiviral (DAA) therapies used to ...
Wednesday, January 23, 2019
Researchers at the University of California, Los Angeles (UCLA) have become the first to successfully develop mature, cancer-killing T cells in a laboratory setting.The immune ...
Tuesday, January 22, 2019
Acupressure has been practiced as part of traditional Chinese medicine for thousands of years. Different pressure points along the body are activated by touch, promoting blo...
Tuesday, January 22, 2019
Although chemotherapy is a potent treatment, it sometimes causes dying cancer cells to become inflamed, triggering the growth of more malignant cells. Researchers have disco...
Monday, January 21, 2019
Previous research has identified an increased risk of metastasis for women diagnosed with breast cancer within five years after giving birth. In a new study, however, researche...

Expert Perspectives

​Brain and spinal cord tumors are the second most common cancers in children, accounting for 1 out of 4 childhood cancers. Despite intensive treatment, children with histologically diagnosed high-risk medulloblastoma, supraten...
Immunotherapies such as PD-1 inhibitors have improved survival for many patients with cancer. However, these therapies are associated with adverse events that, if not properly managed, impair quality of life and may lead to treatm...
For oncology nurses, certification has a significant impact on career advancement and quality care. Since oncology is a rapidly changing field, up-to-date study materials are therefore crucial. To this end, Oncology Nursing Review...
Metastatic breast cancer (MBC) is associated with a poor prognosis, and patients often develop refractory or resistant disease, adverse events, depression, and financial hardship. Mikel Ross, MSN, RN, AGPCNP-BC, OCN®, CBCN®, office practice nurse in ...
Based on recent estimates, kidney cancer accounts for approximately 4% of all cancer diagnoses in the United States. An estimated 65,300 new cases are reported each year and more than 14,000 people die of the disease...

Original Research

In an interview with i3 Health, Mark A. Socinski, MD, shares insights regarding the recent FDA approval of atezolizumab (Tecentriq®, Genentech, Inc.) in combination with carboplatin/paclitaxel/bevacizumab for patients with previou...
In order to identify the continuing medical education needs and preferences of hematology/oncology fellows, i3 Health administered a survey to participants at several live CME-certified visiting faculty meetings. i3 Health inte...
Chronic myeloid leukemia (CML) accounts for 15% of all adult leukemias and is characterized by heterogenous clinical manifestations. In recent years outcomes for patients with CML have greatly improved, in part due to the a...
Many patients with cancer who receive systemic therapy experience cancer treatment-related cognitive impairment, commonly referred to as "chemo brain." Chemo brain is characterized by the inability to remember certain thing...
The incidence of suicide among patients with cancer in the United States is twice that of the general population. Studies demonstrate that demoralization, defined as lowered morale and perceived incapacity to cope, is stron...
© Copyright 2018 i3 Health. All rights reserved.